The recent updates in the Good Distribution Practices by the European Commission. Astra Nova recently released an update of the GDP certification course, that contains all the relevant updates.
This training is based on the international regulations for Good Distribution Practice (GDP) of pharmaceutical products for human use. The training looks into the practices of wholesale distributors and the proper ways and processes concerning the distribution of medicinal products, as well as the roles and responsibilities of all personnel stated in the GDP regulations. It discusses the new EU Guidelines 2013/C 343/01 and measures the impact of the new Falsified Medicines Directive and increasing standards required in a compliant supply chain. The course also takes a detailed look into what are the most important aspects of GDP and provides all trainees with all the most relevant information needed for applying Good Distribution Practices in their work.
WHY IS THIS TRAINING IMPORTANT ?
GDP generally refers to a system of management controls for laboratories and research organisations to ensure the consistency and reliability of results as outlined in the OECD Principles of GDP and other national regulations. The GDP training is required for personnel involved in non-clinical studies, in order for them to be able to follow instructions and important measures.
A summary of the guidelines is available at our corporate website along with a complete preview of the course itself.
You can find the online version of this article here:Good Distribution Practice